← back to search

Nanna Brix Finnerup

Aarhus University · DK
Area of research
Physiology · Neurology
Research interest
Research interests include Pain Mechanisms and Treatments, Botulinum Toxin and Related Neurological Disorders, Musculoskeletal pain and rehabilitation, and Pain Management and Placebo Effect.
h-index
79
citations
43,559
works
513
NIH funding
primary concept
Medicine
email

Recent publications

Somatic and psychological predictors of chronic postsurgical pain in cancer patients: a machine learning approach in a longitudinal two-centre study.
2026cited by 1position: contributordoi
A multicentre randomized double-blind placebo-controlled study of lacosamide, pregabalin, and tapentadol on spinal pain biomarkers
Clinical Neurophysiology 2026cited by 1position: contributordoi
Somatosensory Abnormalities, Dysesthesia and Central Neuropathic Pain in Youth With Cerebral Palsy.
2026cited by 0position: contributordoi
Dermal fibroblast mitochondrial profiles in painful diabetic neuropathy.
2026cited by 0position: contributordoi
Signs of hyperpathia in chronic peripheral neuropathic pain.
2025cited by 2position: contributordoi
The Effect of Fremanezumab on Pain in Patients with Complex Regional Pain Syndrome: Study Protocol of a Randomized, Double-Blind, Proof-of-Concept, Placebo-Controlled Trial
Brain Sciences 2025cited by 1position: middledoi
The Effect of Fremanezumab on Pain in Patients with Complex Regional Pain Syndrome: Study Protocol of a Randomized, Double-Blind, Proof-of-Concept, Placebo-Controlled Trial.
2025cited by 1position: contributordoi
Neuropathic pain in diabetic polyneuropathy: a 5-year prospective study.
2025cited by 0position: contributordoi
The effect of lacosamide in peripheral neuropathic pain: A randomized, double-blind, placebo-controlled, phenotype-stratified trial.
2024cited by 17position: contributordoi
Body image and psychosocial effects in women after treatment of breast cancer: A prospective study.
2024cited by 7position: contributordoi
DREAM: an adaptive, randomised, placebo-controlled trial of duloxetine for reducing leg pain in people with chronic sciatica-trial protocol.
2024cited by 1position: contributordoi
Recommendations for the development, implementation, and reporting of control interventions in efficacy and mechanistic trials of physical, psychological, and self-management therapies: the CoPPS Statement
BMJ 2023cited by 103position: middledoi
Efficacy, safety, and tolerability of antidepressants for pain in adults: overview of systematic reviews
BMJ 2023cited by 93position: middledoi
Joint European Academy of Neurology–European Pain Federation–Neuropathic Pain Special Interest Group of the International Association for the Study of Pain guidelines on neuropathic pain assessment
European Journal of Neurology 2023cited by 90position: middledoi
Central neuropathic pain.
2023cited by 78position: contributordoi
Joint European Academy of Neurology-European Pain Federation-Neuropathic Pain Special Interest Group of the International Association for the Study of Pain guidelines on neuropathic pain assessment.
2023cited by 62position: contributordoi
Efficacy, safety, and tolerability of antidepressants for pain in adults: overview of systematic reviews.
2023cited by 58position: contributordoi
Recommendations for terminology and the identification of neuropathic pain in people with spine-related leg pain. Outcomes from the NeuPSIG working group
Pain 2023cited by 43position: middledoi
Recommendations for terminology and the identification of neuropathic pain in people with spine-related leg pain. Outcomes from the NeuPSIG working group.
2023cited by 28position: contributordoi
Pain in Parkinson disease: mechanistic substrates, main classification systems, and how to make sense out of them
Pain 2023cited by 24position: middledoi
The international spinal cord injury pain basic data set (version 3.0)
Spinal Cord 2023cited by 14position: middledoi
The international spinal cord injury pain basic data set (version 3.0).
2023cited by 14position: contributordoi
Neuropathy and pain after breast cancer treatment: a prospective observational study.
2023cited by 9position: contributordoi
Transition from acute to chronic pain: a misleading concept?
2022cited by 34position: contributordoi
Classification of pain in children with cerebral palsy.
2022cited by 23position: contributordoi
Effects of progressive resistance training in individuals with type 2 diabetic polyneuropathy: a randomised assessor-blinded controlled trial.
2022cited by 13position: contributordoi
Impact of variability in baseline pain on the placebo response in randomized, placebo-controlled, crossover trials in peripheral neuropathic pain.
2022cited by 11position: contributordoi
Not being able to measure what is important, does not make things we can measure important.
2022cited by 5position: contributordoi
IMI2-PainCare-BioPain-RCT1: study protocol for a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by peripheral nerve excitability testing (NET).
2022cited by 4position: contributordoi
Pharmacological Probes to Validate Biomarkers for Analgesic Drug Development.
2022cited by 3position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 32 papers (2019–2026)Troels S. Jensen · Knowledge Centre for Agriculture14 papers (2019–2025)Troels S. Jensen · Steno Diabetes Center13 papers (2013–2020)Andrew S.C. Rice · Imperial College London11 papers (2013–2023)Ralf Baron · Technical University of Munich10 papers (2013–2023)Eva Widerström-Noga · University of Miami9 papers (2012–2023)Hatice Tankisi · Aarhus University9 papers (2019–2026)Rolf‐Detlef Treede · University of Mannheim9 papers (2013–2023) · 8 papers (2013–2023)Simon Haroutounian · The University of Texas MD Anderson Cancer Center8 papers (2015–2023) · 8 papers (2012–2023)Blair H. Smith · Hospital for Sick Children8 papers (2015–2023)Per Hansson · Karolinska Institutet7 papers (2013–2023)Didier Bouhassira · University of Dundee7 papers (2015–2023)G. Cruccu · Sapienza University of Rome6 papers (2015–2023)Srinivasa N. Raja · Johns Hopkins University6 papers (2013–2020)Ian Gilron · University of Rochester Medical Center6 papers (2015–2021)Peter Svensson · National University Health System5 papers (2015–2019)Andrew Moore · McMaster University5 papers (2015–2021)Henning Andersen · Aarhus University Hospital5 papers (2019–2022)